Hatoum H T, Freeman R A
Schering-Plough International, Kenilworth, NJ.
Top Hosp Pharm Manage. 1994 Jan;13(4):47-53.
Pharmacists are encouraged to improve their knowledge and use of pharmacoeconomic data in formulary selection. The formulary selection process has changed significantly in recent years. Among its most significant uses is its potential for cost containment strategies. An overview is presented of the origin as well as the potential impact of pharmacoeconomic data. The need to balance the economic benefit with the clinical advantages for any proposed new drug for formulary inclusion remains the most critical decision to be made by pharmacists.
鼓励药剂师提高他们在药品目录选择中对药物经济学数据的了解和应用。近年来，药品目录选择过程发生了显著变化。其最重要的用途之一是在成本控制策略方面的潜力。本文概述了药物经济学数据的起源及其潜在影响。对于任何拟纳入药品目录的新药，在经济效益与临床优势之间取得平衡的必要性仍然是药剂师要做出的最关键决策。
